Angelika Richter

2.7k total citations
116 papers, 2.1k citations indexed

About

Angelika Richter is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Angelika Richter has authored 116 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Cellular and Molecular Neuroscience, 80 papers in Neurology and 22 papers in Molecular Biology. Recurrent topics in Angelika Richter's work include Neurological disorders and treatments (78 papers), Neuroscience and Neuropharmacology Research (50 papers) and Genetic Neurodegenerative Diseases (34 papers). Angelika Richter is often cited by papers focused on Neurological disorders and treatments (78 papers), Neuroscience and Neuropharmacology Research (50 papers) and Genetic Neurodegenerative Diseases (34 papers). Angelika Richter collaborates with scholars based in Germany, United States and Switzerland. Angelika Richter's co-authors include Wolfgang Löscher, Melanie Hamann, Manuela Gernert, Franziska Richter, Mustapha Bennay, Christin Helmschrodt, Rüdiger Köhling, Christiane Bieber, Stefanie Wilke and Wolfgang Eich and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Brain Research.

In The Last Decade

Angelika Richter

108 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angelika Richter Germany 27 1.3k 1.2k 393 176 156 116 2.1k
Takashi Shiroyama Japan 26 1.0k 0.8× 241 0.2× 545 1.4× 202 1.1× 145 0.9× 55 1.8k
Daniel Martínez‐Fong Mexico 31 1.2k 0.9× 544 0.4× 893 2.3× 62 0.4× 104 0.7× 96 2.6k
James F. Morley United States 24 542 0.4× 1.1k 0.9× 953 2.4× 293 1.7× 41 0.3× 53 3.0k
Anthony L. Hinrichs United States 26 644 0.5× 282 0.2× 1.1k 2.7× 242 1.4× 207 1.3× 57 2.8k
Eleni Koutsilieri Germany 29 623 0.5× 337 0.3× 600 1.5× 148 0.8× 189 1.2× 74 2.6k
John T. Weber Canada 27 789 0.6× 608 0.5× 955 2.4× 32 0.2× 96 0.6× 50 2.5k
Silke Appel‐Cresswell Canada 18 606 0.5× 1.9k 1.5× 638 1.6× 222 1.3× 78 0.5× 46 2.8k
Tamar Gur United States 24 364 0.3× 324 0.3× 667 1.7× 139 0.8× 122 0.8× 49 2.0k
Monty Silverdale United Kingdom 29 569 0.4× 1.6k 1.3× 227 0.6× 145 0.8× 134 0.9× 79 2.3k
Petteri Piepponen Finland 30 1.4k 1.1× 298 0.2× 967 2.5× 188 1.1× 201 1.3× 98 2.9k

Countries citing papers authored by Angelika Richter

Since Specialization
Citations

This map shows the geographic impact of Angelika Richter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelika Richter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelika Richter more than expected).

Fields of papers citing papers by Angelika Richter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelika Richter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelika Richter. The network helps show where Angelika Richter may publish in the future.

Co-authorship network of co-authors of Angelika Richter

This figure shows the co-authorship network connecting the top 25 collaborators of Angelika Richter. A scholar is included among the top collaborators of Angelika Richter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelika Richter. Angelika Richter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Richter, Angelika, et al.. (2025). Off-Label-Use von Antibiotika in der Pferdemedizin – eine anonyme deutschlandweite Online-Umfrage. Tierärztliche Praxis Ausgabe G Großtiere / Nutztiere. 53(3). 155–168.
2.
Schwarz, Štefan, Wolfgang Bäumer, Andrea T. Feßler, et al.. (2024). Critical assessment of commercially available microtitre panels for antimicrobial susceptibility testing of veterinary pathogens. Journal of Antimicrobial Chemotherapy. 80(2). 319–321.
3.
Richter, Angelika, et al.. (2024). Network-wide effects of pallidal deep brain stimulation normalised abnormal cerebellar cortical activity in the dystonic animal model. Neurobiology of Disease. 205. 106779–106779. 1 indexed citations
4.
Richter, Franziska, et al.. (2023). Short-term stimulations of the entopeduncular nucleus induce cerebellar changes of c-Fos expression in an animal model of paroxysmal dystonia. Brain Research. 1823. 148672–148672. 1 indexed citations
5.
6.
Timmermann, Dirk, et al.. (2021). Mechanisms of pallidal deep brain stimulation: Alteration of cortico-striatal synaptic communication in a dystonia animal model. Neurobiology of Disease. 154. 105341–105341. 7 indexed citations
7.
Richter, Franziska, Laura D. Klein, Christin Helmschrodt, & Angelika Richter. (2019). Subtle changes in striatal muscarinic M1 and M4 receptor expression in the DYT1 knock-in mouse model of dystonia. PLoS ONE. 14(12). e0226080–e0226080. 6 indexed citations
8.
Richter, Angelika. (2019). Das Gesetz der Szene. transcript Verlag eBooks.
9.
Richter, Angelika, et al.. (2019). Systematic analysis to assess the scientific validity of the international residue limits for caffeine and theophylline in horse‐racing. Veterinary Record. 185(8). 230–230. 3 indexed citations
10.
11.
Helmschrodt, Christin, et al.. (2016). The novel adaptive rotating beam test unmasks sensorimotor impairments in a transgenic mouse model of Parkinson’s disease. Behavioural Brain Research. 304. 102–110. 12 indexed citations
12.
Richter, Angelika, Melanie Hamann, Jörg Wissel, & Holger A. Volk. (2015). Dystonia and Paroxysmal Dyskinesias: Under-Recognized Movement Disorders in Domestic Animals? A Comparison with Human Dystonia/Paroxysmal Dyskinesias. Frontiers in Veterinary Science. 2. 65–65. 22 indexed citations
13.
Richter, Angelika, et al.. (2006). Striatal microinjections of nitric oxide synthase inhibitors and l-arginine fail to exert effects on paroxysmal dystonia in the dtsz mutant. Neuroscience Letters. 398(1-2). 97–101. 2 indexed citations
14.
Bieber, Christiane, K. G. Müller, Klaus Blumenstiel, et al.. (2006). Long-term effects of a shared decision-making intervention on physician–patient interaction and outcome in fibromyalgia. Patient Education and Counseling. 63(3). 357–366. 121 indexed citations
15.
Köhling, Rüdiger, et al.. (2004). Increased excitability in cortico-striatal synaptic pathway in a model of paroxysmal dystonia. Neurobiology of Disease. 16(1). 236–245. 42 indexed citations
16.
Harnack, Daniel, Melanie Hamann, Wassilios G. Meissner, et al.. (2004). High-frequency stimulation of the entopeduncular nucleus improves dystonia in dtsz hamsters. Neuroreport. 15(9). 1391–1393. 17 indexed citations
17.
Richter, Angelika & Wolfgang Löscher. (1997). Dextrorphan, but not dextromethorphan, exerts weak antidystonic effects in mutant dystonic hamsters. Brain Research. 745(1-2). 336–338. 6 indexed citations
18.
Richter, Angelika & Wolfgang Löscher. (1994). (+)-WIN 55,212-2, a novel cannabinoid receptor agonist, exerts antidystonic effects in mutant dystonic hamsters. European Journal of Pharmacology. 264(3). 371–377. 36 indexed citations
19.
Hau, Stephan, et al.. (1994). "Mutter" und "Vater" in psychoanalytischen Fallvignetten. 12(1). 55–59.
20.
Richter, Angelika, et al.. (1991). Antidystonic effects of the NMDA receptor antagonists memantine, MK-801 and CGP 37849 in a mutant hamster model of paroxysmal dystonia. Neuroscience Letters. 133(1). 57–60. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takashi Shiroyama Breakdown of academic impact, for papers by Daniel Martínez‐Fong Breakdown of academic impact, for papers by James F. Morley Breakdown of academic impact, for papers by Anthony L. Hinrichs Breakdown of academic impact, for papers by Eleni Koutsilieri Breakdown of academic impact, for papers by John T. Weber Breakdown of academic impact, for papers by Silke Appel‐Cresswell Breakdown of academic impact, for papers by Tamar Gur Breakdown of academic impact, for papers by Monty Silverdale Breakdown of academic impact, for papers by Petteri Piepponen
Rankless by CCL
2026